Toolkit · Tort
The Toxic Exposure Claim and Causation Toolkit
42 U.S.C. § 9601
- Type
- Toolkit
- Jurisdiction
- National
- Date
- 2026-06-25
- Topic
- Tort
This toolkit collects the worksheets, letters, and outlines used to build or defend a toxic exposure claim. For a claimant it includes an exposure history worksheet, a product identification log, a coworker witness form, a dose reconstruction intake, a medical records request, a public records request covering environmental and workplace agency files, and a preservation letter. It includes a timeliness analysis worksheet that puts the statute of repose first, expert engagement letters separating general causation from dose and specific causation, a general causation screening memo outline, and a complaint outline. For the admissibility fight it includes a motion outline built around the analytical gap. For defendants it includes a litigation hold, an exposure defense worksheet, and an insurance notice checklist. Lien resolution and settlement grid worksheets close the toolkit, followed by a routing table.
The Toxic Exposure Claim and Causation Toolkit
Tort > Toxic Torts and Environmental Exposure | Published 25 June 2026 - Updated 4 August 2026 | UpLaw - uplaw.us
How to use this toolkit
Bracketed text is a prompt, not language to keep. ⚠ Two cautions. First, ⭐ run Tool 7 — the timeliness analysis — before anything else, because a statute of repose can end a meritorious case regardless of the science. Second, complete Tools 1 through 5 in the first month; the evidence they capture disappears.
Background: toxic torts and environmental exposure and proving what made you sick. Sequence: documenting an exposure and building a toxic tort claim.
Tool 1 — Exposure history worksheet
| Period | Employer / address | Site and building | Job title | Tasks performed | Products used (BRAND) | Ventilation / enclosure | PPE | Hours/week |
|---|---|---|---|---|---|---|---|---|
Also record: ☐ Residence history by address and years ☐ Water source at each address ☐ Distance and direction to industrial facilities ☐ Household exposure — a family member's work clothing ☐ Hobbies and other sources ☐ Bystander exposure — others' work performed nearby
⭐ Brand names and container descriptions matter more than chemical names. Formulations changed by year, and product identification is a threshold issue.
⚠ Complete this immediately. Memory for product names degrades faster than memory for anything else in the case.
Tool 2 — Product identification log
| Product (brand) | Manufacturer, if known | Container description | Years used | Frequency | How identified | Corroboration |
|---|---|---|---|---|---|---|
| [memory / photo / invoice / coworker] |
☐ Photograph any remaining containers or labels ☐ Collect invoices, purchase orders, and receipts ☐ Obtain period safety data sheets — ⚠ the year matters; composition changed ☐ Note any color, size, or logo detail that distinguishes brands ☐ ⭐ Corroborate with at least one coworker per product where possible
Tool 3 — Coworker witness form
Witness: [name] · Contact: [phone, email, address] · Obtained by: [ ] · Date: [ ]
- Employer and dates worked: [ ]
- Job title and location: [ ]
- Did you work with or near [claimant]? When and where? [ ]
- What products were used in that area? [Brand names.]
- How were they used? [Open tanks, spraying, mixing, cutting, cleaning.]
- What did the air look like? [Visible dust, mist, odor.]
- What ventilation existed? [ ]
- What protective equipment was provided and used? [ ]
- Was there any air monitoring? Any warnings or training? [ ]
- Do you have photographs, records, or containers? [ ]
- Who else worked there and where are they now? [ ]
⚠ Collect these now. ⭐ Institutional memory in this field is held by people in their eighties, and a case built ten years later cannot find them.
Tool 4 — Medical records request
[Date] · To: [Provider] · Re: [Patient], DOB [ ]
Please provide the complete record, including:
- All physician, specialist, and consultation notes — ⭐ including the [10] years preceding the diagnosis
- All pathology reports, with cell type, staging, and marker studies
- All imaging reports
- All laboratory results, ⭐ including any blood lead, serum chemical, or metabolite testing
- Occupational and social history documentation
- Any documentation of the patient's or a physician's view of etiology
- Records of any occupational medical surveillance program
[Authorization attached.] Please confirm receipt and provide a production date.
See obtaining, correcting, and protecting medical records and patient rights and medical records.
Tool 5 — Public records request
[Date] · To: [Records custodian, agency] · Re: [Facility name and address], [years]
Under [state public records act / the federal Freedom of Information Act], I request:
Workplace safety agency
- All inspection reports, citations, and abatement records
- All air sampling and industrial hygiene data
- All employee complaints and investigation files
Environmental agency 4. All permits and permit applications, including discharge and air permits 5. All discharge monitoring reports and self-reported data 6. All inspection reports, notices of violation, and consent orders 7. Site assessments, remedial investigations, feasibility studies, and records of decision 8. Groundwater, soil, soil gas, and vapor intrusion sampling data 9. Hazardous waste manifests and generator records
Other 10. Hazardous materials inventories filed with the fire department 11. Water utility testing results for [system], [years] 12. Local health department complaints and investigations
Please identify any withheld records and the exemption claimed. [Fee waiver requested as in the public interest.]
⭐ These records are frequently the best exposure evidence available, cost little, and are not subject to a protective order. The underlying programs are CERCLA at 42 U.S.C. § 9601 with the National Contingency Plan at 40 C.F.R. part 300; RCRA at 42 U.S.C. § 6901 with waste identification at 40 C.F.R. part 261; the Clean Water Act at 33 U.S.C. § 1311; and workplace standards at 29 C.F.R. part 1910.
Tool 6 — Preservation letter
[Date] · To: [Potential defendant; former employer; site owner] · Sent certified
Re: Preservation of evidence — [claimant], exposure at [site], [years]
This firm represents [claimant], who was diagnosed with [disease] on [date] following exposure to [substance] at [site] during [years]. Litigation is anticipated. Preserve the following and suspend all automatic destruction:
- Internal studies, industrial hygiene surveys, and medical department files relating to [substance], from the earliest date available
- All product labels, inserts, warnings, and bulletins, by year
- Formulation and composition records by year and by plant
- Customer, shipment, and invoice records showing product supplied to [site]
- Plant layouts, ventilation designs, process descriptions, and maintenance logs
- All air monitoring, sampling, and medical surveillance data, published or not
- Communications with regulators and trade associations regarding [substance]
- Personnel and assignment records for [claimant] and coworkers
- Prior claims files and testimony regarding [substance]
- Corporate structure, merger, and successor documents
- Insurance policies in effect during [years], including occurrence policies
Preserve metadata and original formats. ⚠ A routine retention policy is not a defense once notice attaches.
[Counsel]
Tool 7 — Timeliness analysis worksheet
⭐ Run this before anything else.
| Question | Finding |
|---|---|
| ⚠ Does this state have a statute of REPOSE for this claim type? | |
| If so, from what act does it run? | |
| Has it expired? | ⚠ If yes, the claim may be barred regardless of merit — CTS Corp. v. Waldburger, 573 U.S. 1, holds federal law does not preempt repose |
| Limitations period for this claim | |
| Date of diagnosis | |
| Date claimant knew or should have known of the cause | |
| Discovery-rule accrual date | |
| Federally required commencement date applicable? | 42 U.S.C. § 9658 preempts earlier state accrual for hazardous substance releases |
| Two-disease rule available? | [Earlier non-malignant diagnosis, later malignancy] |
| Wrongful death / survival periods | ⚠ Frequently different |
| Minority tolling applicable? | |
| Continuing tort or nuisance theory available? | |
| ⭐ Filing deadline |
Tool 8 — Expert engagement letters
⭐ Retain separately by question, and keep each expert in their lane.
General causation — toxicologist or occupational medicine physician
"We ask you to assess whether the peer-reviewed literature supports the conclusion that exposure to [substance] is capable of causing [disease] in humans at doses in the range of [ ]. Please address: the epidemiological studies and their designs; consistency and strength of association; ⭐ whether a dose-response gradient exists; biological plausibility and mechanism; temporality and latency; and the limitations of the literature. Please state clearly the basis for each inference and identify any analytical step that requires extrapolation."
Exposure and dose — industrial hygienist or exposure scientist
"We ask you to assess whether [claimant]'s cumulative exposure to [substance] can be reconstructed from the available evidence, and if so, to estimate it. Please identify the data relied on, the modeling approach, each assumption, and the uncertainty associated with each. ⚠ If reconstruction is not feasible on this record, please say so."
Specific causation — treating or specialist physician
"Assuming general causation is established, we ask you to assess whether [claimant]'s [disease] was caused by exposure to [substance]. Please address exposure, dose, latency, and each alternative cause, ⚠ including [smoking / co-exposures / family history], stating how each was considered."
⚠ Do not ask an industrial hygienist for a medical causation opinion, or a treating physician for a dose estimate. Both are easy exclusions.
Tool 9 — General causation screening memo
1. The disease. [Precise diagnosis, cell type, staging.] 2. The substance. [Chemical, and the specific products.] 3. The literature. [Key cohort and case-control studies; designs; populations; exposure assessment method.] 4. Strength. [Relative risks and confidence intervals; ⚠ note that courts differ on whether a figure above 2.0 is required.] 5. ⭐ Dose-response. [The most persuasive single feature — does more exposure produce more disease?] 6. Consistency. [Across studies and populations.] 7. Mechanism and plausibility. [ ] 8. Latency. [Consistent with this claimant's timeline?] 9. Confounders. [Smoking and co-exposures; how the literature controls for them.] 10. Contrary literature. [⚠ Address it here, not at the deposition.] 11. Assessment. [Can general causation be established? At what dose range?] 12. What would strengthen it. [Additional studies, biomarker, dose refinement.]
⭐ Complete this before filing. ⚠ Filing without it is how cases collapse at the admissibility stage two years later.
Tool 10 — Complaint outline
1. Parties. [Claimant; manufacturers and suppliers; premises owners; site operators. ⚠ Not the employer — workers' compensation exclusivity; see workers' compensation claims.] 2. Jurisdiction and venue. 3. The substance and the products, identified by brand and years. 4. The exposure. [Sites, tasks, duration, conditions.] 5. Defendants' knowledge. [The timeline — studies, warnings history, regulatory correspondence.] 6. Count I — Failure to warn. ⭐ The dominant theory. See product liability. 7. Count II — Design defect. [Safer alternative available.] 8. Count III — Negligence. 9. Count IV — Premises liability, where applicable. See premises liability. 10. Count V — Duty to warn as to an integrated product, where applicable — Air & Liquid Systems Corp. v. DeVries, 586 U.S. 446. 11. Count VI — Nuisance and trespass, for property and community claims. 12. Count VII — Medical monitoring, where recognized. 13. Count VIII — Statutory claims. [Citizen suit under 42 U.S.C. § 6972 or 33 U.S.C. § 1365 or 42 U.S.C. § 7604; cost recovery under 42 U.S.C. § 9607 and 42 U.S.C. § 9613.] 14. Damages, including punitive where the knowledge timeline supports it. 15. Timeliness. [Plead the discovery date affirmatively; address 42 U.S.C. § 9658.]
Tool 11 — Admissibility motion outline
Attacking an opponent's expert:
1. The standard. Federal Rule of Evidence 702; permissible bases under Federal Rule of Evidence 703; the preliminary question under Federal Rule of Evidence 104; balancing under Federal Rule of Evidence 403. Gatekeeping under Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579, extends to all expertise, Kumho Tire Co. v. Carmichael, 526 U.S. 137. 2. ⭐ The analytical gap. [The studies relied on do not support the conclusion drawn — General Electric Co. v. Joiner, 522 U.S. 136. This is the workhorse argument.] 3. General causation not established. [⚠ A differential diagnosis cannot supply it.] 4. Dose unsupported. [Assumptions stacked; no data; modeling unvalidated.] 5. Extrapolation unexplained. [Animal doses orders of magnitude above human exposure.] 6. Alternative causes not addressed. [Smoking; co-exposures; family history.] 7. Methodology created for litigation. 8. Regulatory classification misused as proof of causation.
Defending your own expert: address each of the above in the report itself, ⭐ showing the reasoning chain step by step so no gap is left for the motion to occupy. See expert witnesses and scientific evidence, the witness who decides the case, and the expert witness and daubert challenge toolkit.
Tool 12 — Litigation hold (defense)
To: [All business units, IT, records management, plant management] · From: [Counsel] · Date: [ ]
Re: Preservation obligation — [substance] claims
Preserve, and suspend all destruction of, the following, regardless of retention schedules. ⚠ A routine retention policy is not a defense once notice attaches, and spoliation findings in these matters are severe.
- Research files, internal studies, and industrial hygiene surveys concerning [substance]
- Medical department and employee health files, including surveillance data
- Product labels, inserts, warnings, and bulletins, by year and by market
- Formulation and specification records, by year and by plant
- Sales, shipment, invoice, and customer records
- Plant records: layouts, ventilation design, process descriptions, maintenance
- Air monitoring and sampling data, published or not
- Regulatory submissions and correspondence, and trade association files
- Prior claim files, settlements, and testimony
- Corporate structure, merger, divestiture, and successor documents
- Insurance policies and coverage correspondence for all relevant years
- Communications about [substance] in email, messaging, and shared drives
Preserve metadata and original formats. Direct questions to [counsel].
Tool 13 — Exposure defense worksheet
⭐ Attack exposure, not only causation. The dose gap is frequently the strongest defense available.
| Question | Finding |
|---|---|
| What dose does the plaintiff's expert assert? | |
| What data supports it? | |
| ⭐ What dose was present in the studies relied on? | |
| Ratio between the two | ⚠ Often orders of magnitude |
| Assumptions in the reconstruction | [List each; identify which are unsupported] |
| Was any measurement taken? | |
| Product identification — is it established? | ⚠ Frequently the weakest element |
| Alternative exposure sources | [Other employers, sites, hobbies, household] |
| Alternative disease causes | [Smoking, family history, other conditions] |
| Latency consistent? | |
| Was our product even present at the site in those years? | ⭐ Shipment records |
| Preemption available? | [FIFRA under 7 U.S.C. § 136; other regimes] |
| Statute of repose available? | ⚠ Check first |
| Compensation exclusivity applicable? |
Tool 14 — Insurance notice checklist (defense)
☐ Identify every policy year during the alleged exposure period. ⭐ Occurrence policies from the exposure years — not the diagnosis year — are usually the source of any payment. ☐ Notice every potentially triggered carrier, in every year, ⚠ immediately — late notice defenses have defeated coverage in this field precisely because decades pass between conduct and claim. ☐ Conduct insurance archaeology for missing policies: broker files, ledger entries, premium payments, prior claim files, and secondary evidence. ☐ Determine the trigger theory in the governing state — exposure, manifestation, continuous trigger, or injury-in-fact. ☐ Determine the allocation rule — all sums or pro rata. ☐ Assess the pollution exclusion, absolute or "sudden and accidental," and ⚠ whether it reaches product exposure as distinct from environmental release — courts divide sharply. ☐ Track exhaustion and self-insured retentions to know when excess layers respond. ☐ Preserve the coverage claim while defending the underlying case.
Tool 15 — Lien and offset worksheet
| Source | Amount asserted | Basis | Reduction argument | Resolved |
|---|---|---|---|---|
| Workers' compensation lien | Third-party recovery | [Fee and cost sharing; comparative fault] | ☐ | |
| Health plan subrogation | Plan terms | [Made-whole; common fund] | ☐ | |
| Government program | Statutory | [Procurement cost reduction] | ☐ | |
| Bankruptcy trust recoveries | Setoff rules | [Jurisdiction-specific] | ☐ | |
| Prior settlements | Allocation rule | [Pro rata or pro tanto] | ☐ |
⚠ Resolve every lien before distribution. ⭐ Net recovery, not gross settlement, is what the client experiences — say so at the outset.
Tool 16 — Aggregated proceeding worksheet
☐ Is there an existing consolidated proceeding for this substance and disease? ☐ ⚠ A personal injury class is rarely certified — Amchem Products, Inc. v. Windsor, 521 U.S. 591, and Ortiz v. Fibreboard Corp., 527 U.S. 815. Certification standards: Federal Rule of Civil Procedure 23. ☐ Medical monitoring and property classes remain more viable. ☐ What are the qualification criteria? Diagnosis documentation, exposure threshold, product identification. ☐ ⭐ Grid placement depends entirely on the intake documentation — Tools 1 through 5. ☐ Is there a lien resolution program? ☐ Bellwether selection process and timing. ☐ Opt-out analysis — a real option for a strong individual case, a poor one for a marginal claim. ☐ ⚠ Explain the grid to the client before they form an expectation of individualized valuation. ☐ See class actions and mass claims, joining, opting out of, or bringing a class action, and the class action and mass claim toolkit.
Tool 17 — Routing table
Closing card
⭐ Three things decide these cases: the exposure history written down while the products are still remembered, the agency file obtained by public records request, and the expert report that closes the analytical gap.
⚠ Three failures lose them: filing before screening general causation, missing a statute of repose, and waiting until the coworkers have scattered.
⭐ One question to answer before anything else: from what act does this state's repose statute run, and has it expired?